Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-17-029156
Filing Date
2017-05-03
Accepted
2017-05-03 07:24:54
Documents
15
Period of Report
2017-05-03

Document Format Files

Seq Description Document Type Size
1 6-K a17-12089_16k.htm 6-K 216243
2 GRAPHIC g120891bgi001.gif GRAPHIC 17716
3 GRAPHIC g120891bgi002.gif GRAPHIC 116164
4 GRAPHIC g120891bgi003.gif GRAPHIC 89175
5 GRAPHIC g120891bgi004.gif GRAPHIC 43797
6 GRAPHIC g120891bgi005.gif GRAPHIC 62180
7 GRAPHIC g120891bgi006.gif GRAPHIC 56230
8 GRAPHIC g120891bgi007.gif GRAPHIC 46924
9 GRAPHIC g120891bgi008.gif GRAPHIC 73729
10 GRAPHIC g120891bgi009.gif GRAPHIC 68080
11 GRAPHIC g120891bgi010.gif GRAPHIC 67199
12 GRAPHIC g120891bgi011.gif GRAPHIC 81278
13 GRAPHIC g120891bgi012.gif GRAPHIC 39959
14 GRAPHIC g120891bgi013.gif GRAPHIC 38717
15 GRAPHIC g120891bci001.jpg GRAPHIC 3256
  Complete submission text file 0001104659-17-029156.txt   1326688
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 17807141
SIC: 2834 Pharmaceutical Preparations